This aspect of personalized geroscience could improve treatment outcomes, tailoring therapeutic approaches to an individuals distinct organ aging characteristics in addition to their chronological age
Mo X, Shen L, Cheng R, Wang P, Wen L, Sun Y, et al
If you have diabetes, you should do this in accordance with your treatment plan
Influence of buffering capacity, pH, and temperature on the stability of semaglutide: A preformulation study
You met one of Medicares clinical criteria when you first started GLP-1 therapy
Major trials did not identify anxiety as a primary safety concern, but real-world reports and neurobiological mechanisms suggest susceptible individuals may experience mood shifts during treatment initiation